BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 14509954)

  • 1. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
    Willner J; Jost A; Baier K; Flentje M
    Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
    Piotrowski T; Matecka-Nowak M; Milecki P
    Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of radiation pneumonitis by dose - volume histogram parameters in lung cancer--a systematic review.
    Rodrigues G; Lock M; D'Souza D; Yu E; Van Dyk J
    Radiother Oncol; 2004 May; 71(2):127-38. PubMed ID: 15110445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of related factors associated with radiation pneumonitis in patients with locally advanced non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
    Dang J; Li G; Lu X; Yao L; Zhang S; Yu Z
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1169-78. PubMed ID: 20130912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
    Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
    Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation pneumonitis following twice-daily radiotherapy with concurrent carboplatin and paclitaxel in patients with stage III non-small-cell lung cancer.
    Kobayashi H; Uno T; Isobe K; Ueno N; Watanabe M; Harada R; Takiguchi Y; Tatsumi K; Ito H
    Jpn J Clin Oncol; 2010 May; 40(5):464-9. PubMed ID: 20085905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis.
    Oetzel D; Schraube P; Hensley F; Sroka-Pérez G; Menke M; Flentje M
    Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):455-60. PubMed ID: 7673033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between local dose and loss of function for irradiated lung.
    Gopal R; Tucker SL; Komaki R; Liao Z; Forster KM; Stevens C; Kelly JF; Starkschall G
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):106-13. PubMed ID: 12694828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low dose volume histogram analysis of the lungs in prediction of acute radiation pneumonitis in patients with esophageal cancer treated with three-dimensional conformal radiotherapy].
    Shen WB; Zhu SC; Gao HM; Li YM; Liu ZK; Li J; Su JW; Wan J
    Zhonghua Zhong Liu Za Zhi; 2013 Jan; 35(1):45-9. PubMed ID: 23648300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of two techniques for beam intensity modulation in patients irradiated for stage III non-small cell lung cancer.
    van Sörnsen de Koste J; Voet P; Dirkx M; van Meerbeeck J; Senan S;
    Lung Cancer; 2001 May; 32(2):145-53. PubMed ID: 11325485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
    Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
    Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung Size and the Risk of Radiation Pneumonitis.
    Briere TM; Krafft S; Liao Z; Martel MK
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Importance of dosimetric factors predicting radiation toxicity in lung cancer treatment].
    Letautiene SR; Valuckas KP
    Medicina (Kaunas); 2006; 42(4):314-20. PubMed ID: 16687903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excluding PTV from lung volume may better predict radiation pneumonitis for intensity modulated radiation therapy in lung cancer patients.
    Meng Y; Yang H; Wang W; Tang X; Jiang C; Shen Y; Luo W
    Radiat Oncol; 2019 Jan; 14(1):7. PubMed ID: 30642354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.
    Wang W; Xu Y; Schipper M; Matuszak MM; Ritter T; Cao Y; Ten Haken RK; Kong FM
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):956-63. PubMed ID: 23845844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
    Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.